Ads
related to: thalassemia trait- About Thalassemia
Find more information on
thalassemia & how to manage.
- Managing Thalassemia
There's hope for managing the
symptoms & complications.
- Thalassemia Support
Connect with a Clinical Nurse
Educator for support.
- Sign Up
Take a step forward. Sign up
for thalassemia updates.
- Healthcare Professionals
Please visit this website if
you are a healthcare professional.
- Resources
Find tools to help you get the most
out of your medical appointments.
- About Thalassemia
Search results
Devyser Nabs SEK 3.5M Tender in Italy for Thalassemia Test
GenomeWeb News· 5 days agoDevyser said Monday that it has won a SEK 3.5 million ($333,000) tender to provide in Italy its next-generation sequencing test, which is used to screen for and confirm the hereditary blood ...
Agios (AGIO) Up 23% on Selling Brain Cancer Drug Royalty
Zacks via Yahoo Finance· 4 days agoAgios Pharmaceuticals (AGIO) agrees to sell to Royalty Pharma the rights to royalties on potential...
Agios cashes in on cancer drug again with $905M Royalty Pharma deal
BioPharma Dive via Yahoo Finance· 5 days agoThe deal involves royalties for a brain cancer drug Agios previously sold off and that Royalty...
Agios Breaks Out On 'Buffed Up' Financials After Inking Massive Brain Cancer Deal
Investor's Business Daily· 5 days ago"We view the significantly buffed-up cash position as adding financial flexibility as Agios executes...
Should Abbott and DexCom Investors Be Worried About Vertex Pharmaceuticals?
Motley Fool via Yahoo Finance· 3 days agoHow does Vertex present a threat to Abbott and DexCom? It doesn't -- yet. However, the big biotech...
India urgently needs stem cell donors to fight blood disorders, say experts
Investing.com· 6 days agoNew Delhi, May 27 (IANS) India is urgently in need of stem cell donors to fight blood cancer that...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 2 days agoVertex and partner Crispr Therapeutics gained Food and Drug Administration approval for a...
3 Reasons to Buy CRISPR Therapeutics Stock Like There's No Tomorrow
Motley Fool via Yahoo Finance· 7 days agoCasgevy is about to start ramping up CRISPR's first commercialized product, a gene therapy called...
Is It Too Late to Buy Vertex Pharmaceuticals Stock?
Motley Fool via Yahoo Finance· 7 days agoEarlier this year, the company's gene editing therapy, Casgevy, obtained approval from regulators to treat transfusion-dependent beta thalassemia. Prior...
7 Stocks You Haven't Heard of (That EVERYONE Should Own)
InvestorPlace· 4 days agoThere are many must-own stocks beyond the mega-caps that aren’t household names but have solid...
Ad
related to: thalassemia trait
